Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Nivolumab + Decitabine/THU for Lung Cancer
Recruiting1 awardPhase 2
Cleveland, Ohio
This trial will study whether adding THU to decitabine will improve how well decitabine works against non-small cell lung cancer (NSCLC) when given with the standard of care drug, nivolumab.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.